Fisher Asset Management, LLC
Fisher Asset Management is a other private fund in Camas with $120.95B assets under management.
Company profile
Website
Employees
Incorporated in
Location
Fiscal year end
Industry
Former names
Fisher Investments Inc
SEC CIK
IRS number
202480800
SEC advisor number
801-29362
FINRA CRD number
107342
AUM ?
$120.95B
(as of 23 Mar 20)
Accounts
69,333
(as of 23 Mar 20)
Employees
3,072
(1064 investment advisory or research)
Address
Fisher Asset Management
5525 NW FISHER CREEK DRIVE
CAMAS
WA 98607
5525 NW FISHER CREEK DRIVE
CAMAS
WA 98607
Office hours
Monday - Friday, 7 A.M. TO 5 P.M.
Phone
650-851-3334
Brochures
| Owner | Title | From | %Ownership |
|---|---|---|---|
| Fisher, Kenneth, Lawrence | Executive Chairman, Chairman Board of Managers, Co-chief Investment Officer, Investment Policy Committee | 05/1979 | < 5% |
| Silk, Jeffery, Lee | Vice Chairman, Vice Chairman Board of Managers, Co-chief Investment Officer, Investment Policy Committee | 12/1988 | < 5% |
| Triplett, Steven, Robert | Chief Operating Officer, Board of Managers | 12/2001 | < 5% |
| Ornani, Damian, David | Chief Executive Officer, Board of Managers | 07/2016 | 10-25% |
| Fishel, Thomas, Chapman | Chief Compliance Officer | 01/2005 | < 5% |
| Fisher Investments, Inc. | Member | 04/2005 | > 75% |
| Fisher, Kenneth, Lawrence | Co-trustee | 12/1986 | > 75% |
| Fisher, Nathan, C | Board of Managers | 06/2013 | < 5% |
| Fisher, Sherrilyn | Co-trustee | 12/1986 | > 75% |
| Kenneth L. Fisher and Sherrilyn A. Fisher Family Trust Agreement | Shareholder | 12/2012 | > 75% |
| Fund structure | AUM | Fund type | |
|---|---|---|---|
| Fisher Asset Management, LLC | $120.95B | ||
| Fisher Investments Institutional Group Frontier Markets Equity Fund | $6.3M | Other Private Fund | |
| Fisher Investments Institutional Group Emerging Markets Equity Fund | $455.1M | Other Private Fund | |
| Fisher Investments Institutional Group Small Cap Value Fund | $69.25M | Other Private Fund | |
| Fisher Investments Institutional Group Foreign Equity Fund | $156.11M | Other Private Fund |
Fund data
Regulatory AUM / Assets Under Management
Number of accounts
Number of employees
| Top 50 of 785 long holdings End of quarter 31 Mar 20 |
Value |
#Shares |
Prev Q |
Change %, QoQ |
|---|---|---|---|---|
| $3.56B | 14.02M | 14.03M | -0.1 | |
| $3.38B | 21.46M | 21.33M | +0.6 | |
| $3.27B | 20.32M | 20.2M | +0.6 | |
| $3.16B | 1.62M | 1.77M | -8.3 | |
| $2.58B | 13.26M | 13.18M | +0.6 | |
| $2.53B | 29.69M | 27.35M | +8.6 | |
| $2.05B | 18.39M | 18.94M | -2.9 | |
| $1.97B | 1.69M | 1.68M | +1.0 | |
| $1.63B | 5.13M | 4.13M | +24.3 | |
| $1.57B | 10.87M | 7.27M | +49.6 | |
| $1.54B | 31.42M | 25.62M | +22.6 | |
| $1.5B | 27.8M | 27M | +3.0 | |
| $1.42B | 29.67M | 30.7M | -3.4 | |
| $1.31B | 12.74M | 12.41M | +2.6 | |
| $1.22B | 10.75M | 11.02M | -2.5 | |
| $1.22B | 3.24M | 2.2M | +47.2 | |
| $1.2B | 14.04M | 13.76M | +2.0 | |
| $1.17B | 5.17M | 5.32M | -2.8 | |
| $1.16B | 6.21M | 6.11M | +1.7 | |
|
Fi Enhanced GLBL High Yld Ubs
|
$1.08B | 9.37M | 9.08M | +3.3 |
|
Novo-nordisk a S Adr
|
$922.57M | 15.33M | 15.09M | +1.6 |
|
Fi Enhanced LRG Cap Growth GS
|
$911.67M | 9.18M | 8.22M | +11.6 |
| $903.59M | 3.45M | 2.53M | +36.4 | |
|
Fi Enhanced LRG Cap Growth Ubs
|
$886.26M | 3.83M | 3.94M | -2.8 |
| $877.07M | 3.08M | 3.04M | +1.2 | |
| $859.96M | 3.56M | 482.46K | +637.9 | |
| $853.99M | 7.73M | 7.65M | +1.0 | |
| $824.31M | 20.97M | 30.37M | -30.9 | |
|
LVMH Moet Hennessy Lou Vui Adr
|
$793.21M | 10.68M | 10.41M | +2.6 |
| $772.18M | 17.66M | 17.55M | +0.7 | |
| $748.34M | 20.1M | 19.8M | +1.5 | |
|
Astrazeneca PLC Adr
|
$739.42M | 16.56M | 16.37M | +1.1 |
|
L Oreal Co Adr
|
$732.35M | 13.97M | 13.74M | +1.6 |
| $703.7M | 8.53M | 8.42M | +1.3 | |
| $685.34M | 8.91M | 8.89M | +0.2 | |
| $670.5M | 7M | 4.23M | +65.7 | |
| $650.89M | 5.61M | 5.55M | +1.1 | |
| $642.58M | 3.85M | 310.23K | +1141.8 | |
| $638.39M | 13.21M | 15.96M | -17.3 | |
|
Fi Enhanced GLBL High Yld BCSB
|
$628.5M | 9.69M | 9.92M | -2.4 |
| $601.28M | 4.33M | 4.41M | -1.8 | |
| $601.06M | 19.88M | 20.47M | -2.9 | |
|
Glaxosmithkline PLC Adr
|
$588.81M | 15.54M | 15.41M | +0.8 |
|
Siemens a G Adr
|
$548.7M | 12.91M | 12.85M | +0.5 |
| $543.76M | 6.04M | 5.96M | +1.4 | |
| $528.4M | 3.75M | 1.85M | +102.7 | |
| $522.07M | 14.97M | 14.59M | +2.6 | |
| $507.55M | 11.14M | 11.02M | +1.1 | |
| $487.57M | 5.89M | 30.62K | +19144.2 | |
| $453.86M | 4.81M | 4.77M | +0.9 |
Holdings list only includes long positions.
Only includes long positions.
Calendar
1 Jun 20
31 Dec 20
News
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings
Ownership
13F-HR
Quarterly holdings report by institutional manager
28 Apr 20
13F-HR
Quarterly holdings report by institutional manager
12 Feb 20
SC 13G
Beneficial ownership report
6 Feb 20
13F-HR
Quarterly holdings report by institutional manager
29 Oct 19
13F-HR
Quarterly holdings report by institutional manager
30 Jul 19
13F-HR/A
Quarterly holdings report by institutional manager (amended)
22 Apr 19
13F-HR
Quarterly holdings report by institutional manager
22 Apr 19
SC 13G/A
Stratasys LTD.
1 Feb 19
13F-HR
Quarterly holdings report by institutional manager
25 Jan 19
13F-HR
Quarterly holdings report by institutional manager
24 Oct 18